Invention Grant
US08697087B2 Influenza vaccines including combinations of particulate adjuvants and immunopotentiators 失效
流感疫苗,包括颗粒状佐剂和免疫增强剂的组合

  • Patent Title: Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
  • Patent Title (中): 流感疫苗,包括颗粒状佐剂和免疫增强剂的组合
  • Application No.: US12092162
    Application Date: 2006-11-06
  • Publication No.: US08697087B2
    Publication Date: 2014-04-15
  • Inventor: Rino RappuoliDerek O'HaganGiuseppe Del Giudice
  • Applicant: Rino RappuoliDerek O'HaganGiuseppe Del Giudice
  • Applicant Address: CH Basel
  • Assignee: Novartis AG
  • Current Assignee: Novartis AG
  • Current Assignee Address: CH Basel
  • Agent Helen Lee; Otis Littlefield
  • International Application: PCT/GB2006/004133 WO 20061106
  • International Announcement: WO2007/052058 WO 20070510
  • Main IPC: A61K39/39
  • IPC: A61K39/39 C12N1/20
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
Abstract:
Influenza vaccines containing insoluble particulate adjuvants have been found to elicit an IgG response that is primarily a TH2 response (IgG1). This response can be shifted towards a TH1 response (IgG2a) by including immunopotentiators in the compositions. Thus the invention provides an immunogenic composition comprising: (i) an influenza virus antigen; (ii) an insoluble particulate adjuvant; and (iii) a immunopotentiator.
Information query
Patent Agency Ranking
0/0